Improved fluorescence assays to measure the defects associated with F508del-CFTR allow identification of new active compounds

- Langron, Emily, Simone, Michela I., Delalande, Clémence M. S., Raymond, Jean-Louis, Selwood, David L., Vergani, Paola

Selective inhibition of the mitochondrial permeability transition pore protects against neurodegeneration in experimental multiple sclerosis

- Warne, Justin, Pryce, Gareth, Chan, A. W. Edith, Towers, Greg J., Coker, Alun R., Duchen, Michael R., Szabadkai, Gyorgy, Baker, David, Selwood, David L., Hill, Julia M., Shi, Xiao, Lennerås, Felicia, Puentes, Fabiola, Kip, Maarten, Hilditch, Laura, Walker, Paul, Simone, Michela I.

2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion

- Sayer, James R., Walldén, Karin, Waksman, Gabriel, Tabor, Alethea B., Pesnot, Thomas, Campbell, Frederick, Gane, Paul J., Simone, Michela, Koss, Hans, Buelens, Floris, Boyle, Timothy P., Selwood, David L.

2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion

- Sayer, James R., Walldén, Karin, Waksman, Gabriel, Tabor, Alethea B., Pesnot, Thomas, Campbell, Frederick, Gane, Paul J., Simone, Michela, Koss, Hans, Buelens, Floris, Boyle, Timothy P., Selwood, David L.

Endothelial C-type natriuretic peptide maintains vascular homeostasis

- Moyes, Amie J., Khambata, Rayomand S., Simone, Michela I., Mota, Filipa, Rivilla, Fernando, Vallejo, Susana, Peiró, Concepcion, Sánchez Ferrer, Carlos F., Djordjevic, Snezana, Caulfield, Mark J., MacAllister, Raymond J., Selwood, David L., Villar, Immaculada, Ahluwalia, Amrita, Hobbs, Adrian J., Bubb, Kristen J., Baliga, Reshma S., Lumsden, Natalie G., Xiao, Fang, Gane, Paul J., Rebstock, Anne-Sophie, Worthington, Roberta J.